Search Results 1741-1750 of 14839 for Venlafaxine

1. A Study to Analyze Biopsy of Vascular Malformations - Mayo Clinic

   The purpose of this study is to validate a core biopsy technique for obtaining tissue from treatment naive vascular anomalies for clinical pathology and genomic ...

2. Primary Tumor Research and Outcome Network (PTRON) Registry - Mayo Clinic

   About this study. The purpose of this registry is to collect clinical, diagnostic, and therapeutic data specific for primary spinal column tumor patients, ...

3. A Dose Escalation Study of Amivantamab in Participants with Advanced Non-Small Cell Lung Cancer - Mayo Clinic

   The purpose of this study is to evaluate the safety and pharmacokinetics, establish a recommended phase 2 dose (RP2D) regimen, and to assess the preliminary ...

4. Patient Stories - N. Nora Bennani, M.D. - Mayo Clinic

   Their crucial work saves lives every day. Let Mayo Clinic researchers know they're appreciated with a quick message.

5. A Second Trial of the Abbreviated Protocol Two-Stage Exchange - Mayo Clinic

   Also, to evaluate superiority at 365 days in a composite endpoint of Overall Success, overall safety of the VT-X7 procedure, quality of life (QoL), and patient ...

6. Publications - Cyril Varghese, M.D., M.S. - Mayo Clinic

   Varghese C, Johnson GB, Eiken PW, Edell ES, Specks U, Larson NB, Peikert T. A Retrospective Evaluation of the Treatment Effects of Rituximab in Patients ...

7. Nusinersen (Intrathecal Route) Description and Brand Names - Mayo Clinic

   Nusinersen injection is used to treat spinal muscular atrophy (SMA).

8. Platelet Rich Plasma Versus Minoxidil Foam for Treatment of Androgenic Alopecia in Women - Mayo Clinic

   The primary objective of this proposal is to conduct a study that assesses the safety, feasibility and efficacy of using PRP to treat this type of hair loss.

9. A Study to Assess Epicardial Delivery of XC001 Gene Therapy for Refractory Angina Coronary Treatment (The EXACT Trial) - Mayo Clinic

   The primary purpose of this trial is to determine the safety of XC001 (AdVEGFXC1) in patients who suffer from angina caused by coronary artery disease and have ...

10. A Study to Evaluate the Safety and Immunological Effect of Pembrolizumab in Resectable or Borderline Resectable Pancreatic Cancer - Mayo Clinic

    Pembrolizumab has been approved for treatment of patients with melanoma but has not been proven to be safe or helpful in patients with pancreatic cancer and is ...